Home >> Blog >> Mukka Proteins Ltd. IPO - Review, Valuation, Date & GMP
Mukka Proteins Ltd. IPO - Review, Valuation, Date & GMP
Table of Contents
- Mukka Proteins Limited IPO - Complete Overview
- Mukka Proteins Limited IPO Overview
- Company Financial
- The Objective of the Issue
- Peers of Mukka Proteins Limited IPO
- Evaluation
- IPO's Strengths
- IPO's Weaknesses
- IPO GMP Today
- Mukka Proteins Limited IPO timetable (Tentative)
- Mukka Proteins Limited IPO Details
- Promoters and Management of Mukka Proteins Limited IPO:
- Mukka Proteins Limited IPO Lead Managers
- Dividend Policy
- Conclusion
Mukka Proteins Limited IPO - Complete Overview
Established in March 2003, Mukka Proteins Limited is a top-notch fish protein product manufacturer. The company creates and delivers essential ingredients like fish meal, fish oil, and fish soluble paste, crucial for making aqua feed (for fish and shrimp), poultry feed (for broilers and layers), and pet food (for dogs and cats).
Mukka Proteins exports its goods to over 10 countries, including Bahrain, Bangladesh, Chile, Indonesia, Malaysia, Myanmar, Philippines, China, Saudi Arabia, South Korea, Oman, Taiwan, and Vietnam.
As of March 31, 2023, the company employs 385 people across various departments. It operates six production facilities, with four in India and two owned by its foreign subsidiary, Ocean Aquatic Proteins LLC, in Oman. Additionally, the company manages three blending plants and five storage facilities, all strategically located near the coast.
Certified by NQA and UKAS to ISO 22000:2018 and ISO 9001:2015 standards, Mukka Proteins ensures world-class quality.
Mukka Proteins plays a key role in the fish protein product industry, meeting the global demand for quality products.
Mukka Proteins Limited IPO Overview
Mukka Proteins Limited IPO date is slated to be open for subscription from February 29, 2024, to March 4, 2024. This BSE NSE IPO follows a Book Built Issue IPO.
Mukka Proteins Limited IPO price is fixed at Rs.26 - Rs.28 per share.
The total issue size of this IPO amounts to Rs. 224 CR. The company has reserved 50% for institutional investors, 15% for non-institutional investors, and 35% for retail investors.
Company Financial
In FY23, the company experienced significant growth compared to FY22 in financials.
(Amount in Crore)
Period |
Sep 30 FY 23 |
Mar 31 FY 23 |
Mar 31 FY 22 |
Total Assets |
641.18 |
575.16 |
392.30 |
Total Revenue |
612.88 |
1,183.80 |
776.15 |
PAT |
32.98 |
47.53 |
25.82 |
Net worth |
159.11 |
128.92 |
87.25 |
Reserve & Surplus |
144.92 |
112.57 |
68.51 |
Total Borrowings |
317.73 |
254.83 |
173.50 |
Revenue Distribution Product-Wise
In FY23, revenue for fish meal, fish oil, and fish soluble paste increased compared to FY22, totaling ₹1,154.30 Crore, up from ₹765.73 Crore.
(Amount in Crore)
Particulars |
Sep 30 FY 23 |
Mar 31 FY 23 |
Mar 31 FY 22 |
Fish meal |
522.17 |
962.07 |
712.08 |
Fish oi |
53.66 |
165.32 |
32.55 |
Fish soluble paste |
13.64 |
26.91 |
21.10 |
Total |
589.48 |
1,154.30 |
765.73 |
Revenue Distribution State-Wise
In FY23, Indian revenue tripled to Rs.1,901.21 Crore, and international revenue rose to Rs.3,993.66 Crore, resulting in total revenue growth from Rs.765.73 Crore to Rs.1,154.30 Crore compared to FY22.
(Amount in Crore)
Particulars |
Sep 30 FY 23 |
Mar 31 FY 23 |
Mar 31 FY 22 |
Within India revenue |
1,901.21 |
486.50 |
569.32 |
Outside India revenue |
3,993.66 |
667.80 |
196.41 |
Total |
589.48 |
1,154.30 |
765.73 |
Revenue by Operations
In FY23, revenue from operations increased from ₹7,70.50 Crore to ₹11,77.12 Crore, and total revenue grew from ₹776.14 Crore to ₹1,183.80 Crore compared to FY22.
(Amount in Crore)
Particulars |
Sep 30 FY 23 |
Mar 31 FY 23 |
Mar 31 FY 22 |
Revenue from operations |
6,06.09 |
11,77.12 |
7,70.50 |
Other Income |
6.78 |
6.68 |
5.64 |
Total Revenue |
612.88 |
1,183.80 |
776.14 |
The Objective of the Issue
The company intends to use the net proceeds for the following objectives.
-
Meeting the Company's working capital needs;
-
Providing financial support to the Associate, namely Ento Proteins Private Limited, to address its working capital requirements;
-
Covering general corporate expenses.
Peers of Mukka Proteins Limited IPO
Mukka Proteins Limited IPO has a face value of Rs. 1 per share, a P/E ratio of 14.00, and an EPS of Rs. 2.00, with comparable metrics to its peers .
Name of the Company |
Face Value (Rs. per share) |
P/ E |
EPS (Basic) (Rs.) |
Mukka Proteins Limited |
1.00 |
14.00 |
2.00 |
Avanti Feeds Ltd. |
1.00 |
25.00 |
20.45 |
Godrej Agrovet Ltd |
10.00 |
33.23 |
15.71 |
Zeal Aqua Ltd |
1.00 |
20.63 |
0.56 |
Waterbase Ltd. |
10.00 |
-0.84 |
Evaluation
The IPO is priced within the range of Rs. 26 - Rs. 28 per share.
Evaluation of P/E Ratio:
- Considering the FY23 EPS of Rs 2.00 from the last year, the resulting P/E ratio is 14.00x.
- Taking into account the weighted EPS of Rs 1.44 for the last three years, the P/E ratio amounts to 19.44x.
Comparative Analysis with Listed Peers:
- Godrej Agrovet Limited has a P/E ratio of 33.23x (the highest).
- Zeal Aqua Limited has a P/E ratio of 20.63x (the lowest).
- The industry's average P/E is 26.29x.
As a result, the IPO price range, with a P/E ratio ranging from 14.00x to 19.44, seems slightly undervalued in comparison to the industry average of 26.29.
IPO's Strengths
- Leading manufacturer and exporter of fish protein products.
- Consistent recognition by MPEDA for outstanding export performance over the last 7 years.
- Dominant market share of 45-50% in India's fish meal and fish oil industry for FY 2022.
- Long-standing relationships with key customers in aqua feed, poultry feed, and pet food sectors.
- World-class quality certified plants strategically located in India.
- In-house research and development capabilities.
- Extensive pan-India sales network with well-equipped and automated manufacturing facilities.
IPO's Weaknesses
- Heavy reliance on export revenue exposes the company to significant exchange rate-related risks.
- Vulnerability to disruptions in an environmentally sensitive industry, especially due to unpredictable or unseasonal weather.
- Potential risks include failure to meet specified quality standards for fish meal, fish oil, and fish soluble paste.
- Threat of widespread contamination due to man-made factors affecting pelagic fish populations.
IPO GMP Today
The Latest GMP of Mukka Proteins Limited IPO is Rs.35.
Mukka Proteins Limited IPO timetable (Tentative)
Events |
Date |
IPO Opening Date |
29 February 2024 |
IPO Closing Date |
4 March 2024 |
IPO Allotment Date |
5 March 2024 |
Refund initiation |
6 March 2024 |
IPO Listing Date |
7 March 2024 |
Mukka Proteins Limited IPO Details
IPO opening & closing date |
29 February to 04 March |
Face Value |
Rs.1 per share |
Issue Price |
Rs. 26- Rs.28 per share |
Lot Size |
535 Shares |
Price of 1 lot |
Rs.14,980 |
Total Issue Size |
80,000,000 shares (aggregating up to Rs. 224.00 Cr) |
Fresh issue |
80,000,000 shares (aggregating up to Rs. 224.00 Cr) |
Listing at |
BSE NSE |
Issue Type |
Book Built Issue IPO |
Registrar |
Cameo Corporate Services Limited |
Mukka Proteins Limited IPO Lot Details:
Application |
Lot |
Shares |
Amount |
Minimum Lot Investment (Retail) |
1 lot |
535 |
Rs.14,980 |
Maximum Lot Investment (Retail) |
13 lot |
6955 |
Rs.1,94,740 |
Minimum Lot Investment (HNI) |
14 lot |
7,490 |
Rs.2,09,720 |
Maximum Lot Investment (HNI) |
66 lot |
35,310 |
Rs.9,88,680 |
Mukka Proteins Limited IPO Reservation
QIB Shares Offered |
Maximum 50% |
Retail Shares Offered |
Minimum 35% |
Other Shares Offered |
Minimum 15% |
Promoters and Management of Mukka Proteins Limited IPO:
1. Kalandan Mohammed Haris.
2. Kalandan Mohammad Arif.
3. Kalandan Mohammed Althaf.
Pre-issue Promoter Shareholding |
100% |
Post-issue Promoter Shareholding |
Mukka Proteins Limited IPO Lead Managers
-
Fedex Securities Pvt Ltd
Dividend Policy
The company hasn't paid dividends in past fiscal years. Whether we can pay them in the future depends on factors like profits, past dividend trends, capital needs, legal restrictions, and other relevant considerations evaluated by our Board.
Conclusion
Mukka Proteins Limited IPO presents financial metrics like a face value of Rs. 1 per share, a P/E ratio of 14.00, and an EPS of Rs. 2.00. While these figures provide insights into the company's standing, deciding whether it's a good or bad investment requires a comprehensive analysis of individual investment preferences, risk tolerance, and market conditions. Prospective investors are encouraged to conduct thorough research and seek professional advice before making any investment decisions.
Finowings IPO Analysis
Hope you enjoyed the Finowings IPO Analysis. We tried our best to give every required detail about the company that you should know before applying to the IPO.
You must consult your financial advisor before making any financial decisions.
To Apply for the IPO, Click Here.
To Read the Prospectus of the Company Click Here to Download the DRHP.
Thank You for reading this blog.
Hope you loved the IPO analysis.
Please Comment Below with your feedback because Your feedback motivates us to deliver more such content.
Follow MUKUL AGRAWAL for the latest IPO news and reviews. You can connect with us on social media platforms like Twitter, Facebook, and Instagram. You can also subscribe to our YouTube Channel for the latest videos of the stock market.
Frequently Asked Questions
The face value per share is Rs. 1.
Mukka Proteins Limited's P/E ratio is 14.00, and investors should assess this in relation to industry benchmarks and peer companies.
The EPS is Rs. 2.00, indicating the company's earnings per outstanding share.
The comparison table shows key metrics for Mukka Proteins Limited and its Peers, assisting investors in evaluating relative performance.
The recommendation depends on various factors, and investors are advised to conduct thorough research, consider their financial goals, and seek professional advice before making investment decisions.
V.Jayaprakash | Posted on 28/02/2024
Good IPO